Moftah et al. designed and synthesized a series of quinazolinone-based derivatives as novel, multifunctional anti-AD drugs that exhibit both cholinesterase inhibitory and anti-inflammatory properties. This evidence concerns the gene BCHE and Alzheimer disease.